Latest news
Nuvation Bio (NUVB) surges to $114.9M revenue and issues $250M notes - Stock TitanStock Titan · Thu, 06 Aug 2026 10:55:57 GMTCORE Biomedicine Deepens Precision Oncology Pipeline With $21 Million Funding Round and Eisai Licensing Deal - TipRanksTipRanks · Sat, 01 Aug 2026 16:03:02 GMTEisai and CORE Biomedicine agree on global licence for oncology pipeline - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTCORE Biomedicine Secures Global Rights to Eisai Oncology Portfolio to Advance Precision Cancer Therapies - TipRanksTipRanks · Tue, 28 Jul 2026 13:34:39 GMTCORE Biomedicine Signs Exclusive Licensing Agreement with Eisai for Precision Oncology Programs - PR NewswirePR Newswire · Tue, 28 Jul 2026 12:21:00 GMT